Arkolith/Insider Trading/NAUT/Form 4

Patel Sujal M

CEO, President, and Secretary, Director, 10% OwnerNautilus Biotechnology, Inc. (NAUT) · full profile →Form 4 · filed Mar 4, 2026
Net Buying
Open-Market Buys
$65K
Open-Market Sells
$0
Net Open-Market Flow
$65K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Buy(P)25K$2.61$65K10.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001378830-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML